- Home
- KNSA vs JPC Comparison
KNSA vs JPC Comparison
Compare KNSA & JPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- JPC
- Stock Information
- Founded
- KNSA 2015
- JPC 2003
- Country
- KNSA United Kingdom
- JPC United States
- Employees
- KNSA N/A
- JPC N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- JPC Investment Managers
- Sector
- KNSA Health Care
- JPC Finance
- Exchange
- KNSA Nasdaq
- JPC Nasdaq
- Market Cap
- KNSA 2.6B
- JPC 2.9B
- IPO Year
- KNSA 2018
- JPC N/A
- Fundamental
- Price
- KNSA $38.36
- JPC $8.14
- Analyst Decision
- KNSA Strong Buy
- JPC
- Analyst Count
- KNSA 7
- JPC 0
- Target Price
- KNSA $49.71
- JPC N/A
- AVG Volume (30 Days)
- KNSA 546.2K
- JPC 998.5K
- Earning Date
- KNSA 10-28-2025
- JPC 01-01-0001
- Dividend Yield
- KNSA N/A
- JPC 7.57%
- EPS Growth
- KNSA N/A
- JPC N/A
- EPS
- KNSA 0.47
- JPC N/A
- Revenue
- KNSA $597,973,000.00
- JPC N/A
- Revenue This Year
- KNSA $62.63
- JPC N/A
- Revenue Next Year
- KNSA $29.93
- JPC N/A
- P/E Ratio
- KNSA $82.19
- JPC N/A
- Revenue Growth
- KNSA 55.68
- JPC N/A
- 52 Week Low
- KNSA $17.82
- JPC $5.94
- 52 Week High
- KNSA $42.05
- JPC $7.36
- Technical
- Relative Strength Index (RSI)
- KNSA 52.71
- JPC 50.24
- Support Level
- KNSA $36.56
- JPC $8.12
- Resistance Level
- KNSA $39.66
- JPC $8.19
- Average True Range (ATR)
- KNSA 1.58
- JPC 0.06
- MACD
- KNSA -0.13
- JPC 0.00
- Stochastic Oscillator
- KNSA 50.78
- JPC 65.63
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About JPC Nuveen Preferred & Income Opportunities Fund
Nuveen Preferred & Income Opportunities Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. It invests its managed assets in preferred securities, and in other types of securities, primarily income-oriented securities such as corporate and taxable municipal debt and common equity.